Abstract
Patient organisations failed to declare over £14m (€15.3m; $18m) in payments from pharmaceutical companies between 2012 and 2016, according to a study from BMJ Open .1 The paper compared drug...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
